Taro Tokita

RBG Partners KK engages in the operation and management of investment business partnership assets. It also deals with the acquisition and holding of securities and offers consulting services for company diagnosis and investment planning. The company was founded on October 2, 2018 and is headquartered in Yokohama, Japan.

Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million.

SMBC Venture Capital KK (SMBC Venture Capital) is a Private Equity firm, a subsidiary of Sumitomo Mitsui Banking Corp., itself a subsidiary of publicly traded company Sumitomo Mitsui Financial Group, Inc. (TK:8316) founded in 2005. The firm is headquartered in Tokyo.